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In  a  previous study,  the  expression of certain murine  cell surface  antigens  was 
measured in hybrid cells derived from  the fusion of various normal and malignant 
cells (1,  2). As a rule, the antigens contributed by both parental cells were expressed 
in the hybrid cell in a codominant fashion, as in cells from heterozygous animals pro- 
duced by normal genetic crossing. There was one notable exception to this rule..All 
hybrids produced by the fusion of an Ehrlich ascites tumor cell with other partners 
showed some suppression of the antigens introduced into the hybrid cell by the other 
partner. This was true both for the genetically defined antigens of the H-2 complex 
and for non-H-2 antigens such as the surface antigen (FMR type), determined by a 
C-type virus carried by the L cell line, and the L  antigen, another antigenic marker, 
specific for the L  cell. Progressive chromosome loss occurs during prolonged passage 
of these hybrid cells in vitro or in vivo, and associated with this loss, the initial anti- 
genic  suppression may be  abolished. In several sublines produced in  this way the 
missing antigenic phenotype was reacquired fully or in part (2,  3). 
The suppression of surface antigens in the Ehrlich hybrids was thus "dominant." 
The  fact that  antigens determined in very different ways were  suppressed en  bloc 
suggested that the suppression mechanism might operate at a rather peripheral level, 
perhaps by  the  deposition of some masking substance on the outer cell membrane. 
The Ehrlich tumor has been selected for progressive growth by passage in genetically 
foreign (allogeneic) mice for 75 yr. The selection pressure favoring cells with reduced 
antigen expression was therefore extreme in this cell line. The question arises whether 
immunoresistance in other cell lines, not selected in this way, is produced by mecha- 
nisms similar to those operating in the Ehrlich tumor. 
To examine this question, we tested antigenic expression in another series of hybrid 
cells. The mammary carcinoma TA3, of strain A origin, was chosen for study because 
there are two sublines of it that differ greatly in the concentration of H-2~ antigen 
they contain and in their homotransplantability. The tumor arose in a strain A/HeHa 
mouse in Dr. T. S. Hauschka's laboratory in 1949 (4) and was subsequently converted 
to the ascites form (5). One ascites subline was brought to Stockholm while the other 
was passaged further by Dr. Hauschka. The Stockholm line (designated TA3/St) has 
maintained a  high H-2  ~ expression and  is readily rejected by allogeneic mice. The 
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American line (designated TA3/Ha)  has a  reduced H-2'* concentration and grows  in 
genetically  foreign strains of  mice.  Details  of  the cytological and biological charac- 
teristics  of  the  two  TA3  lines  will  be  published  elsewhere.:, ~  Unlike  the  Ehrlich 
tumor, the TA3/Ha line has never been subjected to any known selection for growth 
in allogeneic hosts.  Its antigen expression and transplantation specificity  decreased, 
for unknown reasons,  during serial passage of the tumor  in syngeneic strain A  mice 
(T.  S.  Hauschka,  personal communication). 
In the course of a  study concerned with the expression of malignant behavior 
in  hybrid  cells  derived  from  the  fusion  of  normal  and  malignant  cells  (6),  a 
series of  hybrid  clones was  produced  by  fusing  the TA3/Ha  cell with  diploid 
fibroblasts explanted directly from embryonic ACA  (H-2:)  :nice. Quantitative 
studieson  the H-2 antigen expression of the hvbrids are described in the  present 
paper. 
Materials and Methods 
Cells.-  The origin of the TA3 mammary tumor, derived from a  strain A/HeHa breeding 
female in Dr.  T.  S.  Hauschka's laboratory in  1949, has been described  (4).  The tumor was 
converted to the ascites form on two separate occasions and both lines were carried by serial 
intraperitoneal passage in syngeneic recipients. The subline designated TA3/St was brought 
to~ Stockholm by one of us (G. K.) in 1951, whereas the other line, designated TA3/Ha, was 
maintained by Dr. T. S. Hauschka at the Roswell Park Memorial Institute in Buffalo, N.Y. 
The Stockholm subline grows progressively in 100% of syngeneie strain A mice and is regularly 
rejected  by allogeneic recipients,  even if high challenge doses are inoculated  (105  and  108 
cells).:, 2 The Hauschka subline grows indiscriminately in allogeneic H-2-incompatible mice 
(7) ; it has lost strain specificity without any known selection pressure. It was received in our 
laboratory  from  Dr.  T.  S.  Hauschka  in  1969  and was  subsequently maintained by  serial 
passage in syngeneic recipients. 
The TA3/Ha line was fused with trypsinized mouse embryo fibroblasts of the ACA (H-2/) 
strain as ~described previously (6).  TA3 cells grow well as a monolayer on the plastic surface 
and they outgrow the hybrid cells in the initial fused cell population. Since no selective pro- 
cedures were available to isolate the hybrid cells from the parental cells,  a  large number of 
clones were grown from  the fused  cell population.  Clones showing a  clearly different mor- 
phology from the tumor cells or the normal fibroblasts were isolated and grown up as separate 
subpopulations. A number of them turned out to be hybrid cells on karyological examination. 
Hybrid  cell  lines  were  thus  established  from  the  original  clones.  Clones  designated 
TA3/Ha/ACA  clones 2,  3B, 4, 5, 6, 7,  10, 11, and 12 were used for antigenic typing and the 
results are described in the present paper.  Studies on  the tumorigenicity of  these lines are 
reported elsewhere. 
All hybrid lines were grown as monolayers in plastic flasks on Dulbecco's medium (8) with 
10% fetal calf serum and the following antibiotics: penicillin 200 #g, streptomycin 200/zg, 
kanamycin 30 #g, neomycin 30 #g, and Mycostatin 40 #g/ml  (E. R. Squibb and Sons, New 
York). 
Embryonic fibroblasts, derived from strain A, ACA, and (A X  ACA)F: mice, were used as 
controls in some of the absorption experiments. For this purpose,  8-14-day-old embryos of 
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the required genotype were decapitated, eviscerated, and cut into small fragments. The pieces 
were trypsinized (0.25%)  for 60 min at 37°C, washed twice, and seeded into 75-cm 2 plastic 
tissue culture  bottles  (No.  3024,  Falcon Plastics, Division of B-D  Laboratories, lnc., Los 
Angeles, Calif.) in Eagle's minimal essential medium supplemented with 10% fetal calf serum. 
The cells  that settled within 24  hr were rinsed with fresh medium and subcultured when 
confluent. Only second-passage flbroblasts were used in the absorption studies. TA3/St and 
TA3/Ha  cells were established as in vitro lines by explantation of the ascites tumors. The 
tumor cell lines were maintained in the same way as the flbroblasts. 
Antisera.--Isoantisera  were produced  by  immunizing groups  of  10-13  adult  mice with 
pools of normal tissues. Cell suspensions prepared from the spleen, kidney, and liver were 
injected subcutaneously once every 2 wk for 14-24 wk. The micewere bled 7-10 days after the 
last injection. 
To identify K-end antigens of the H-2 a complex, an ACA X  C57BL  anti-C3H serum was 
used.  D-end antigens of  the  H-2 a  complex were identified with a  monospecific anti-H-2  d 
serum (pool C4)  obtained from the Transplantation  Reference Center, National  Institutes 
of Health, Bethesda, Md. C4 is a  (C3H.SW  X  AKR.M)F1  anti-B10.A  ([H-2 b  X  H-2"qF1 
anti-H-2 a)  serum. To  identify the  ACA-derived II-2  f  antigens, an A  anti-ACA serum was 
used. All sera were stored frozen at --20°C. 
Absorption  Tesls.--To  measure the concentration of H-2a-determined  isoantigens on the 
surface of the two TA3  sublines, the various TA3/Ha/ACA hybrid clones, and the normal 
embryonic fibroblasts, quantitative absorption tests were run  against standard antiserum- 
target cell systems. 
To measure the antigens specified by the K-end of the H-2 a complex (9), strain A lympho- 
cytes were exposed to an anti-H-2 k  (ACA  X  C57BL anti-C3H)  serum, in the presence of 
complement, unabsorbed and  after absorption with  various  numbers of  test  cells.  D-end 
antigens of the H-2 a complex were measured by testing the C4 antiserum pool against strain 
A lymphocytes, before and after adsorption. Antigens specified  by the ACA-derived (H-2 f) 
antigen complex were measured by absorbing the A anti-ACA serum and testing its cytotoxic 
activity against ACA lymphocytes. 
For the absorption test, the two TA3  tumor lines maintained in vitro were harvested by 
shaking the bottles and centrifuging the suspension. The hybrid ceils were harvested with a 
rubber policeman and used directly. Embryonic fibroblasts were brought into suspension with 
0.02%  ethylenediaminetetraacetate and filtered through a  double layer of gauze to remove 
cell clumps. All cell suspensions were diluted to yield cell numbers ranging from 10 a to 10  ~. 
The requisite cell numbers were introduced into small centrifuge tubes. After centrifugation, 
the supernatants were removed from the tightly packed cell pellets; 25 #1 of antiserum at an 
appropriate dilution was then added to each tube. The unadsorbed antiserum was standardized 
against the target lymphocytes; the highest dilution that gave a  cytotoxic index between 
0.8 and 1.0 was chosen as the standard. The working dilution varied between 1 : 12 and 1 : 128 
with the different antisera. The mixture of cells and antiserum was incubated at 37°C for 45 
min. The cells were then removed by centrifugation, and the supernatant was stored frozen 
at --20°C until required for assay. 
Lymph nodes of adult mice of the appropriate strain were minced in a balanced salt solu- 
tion. Tissue fragments and large clumps of cells were removed by sedimentation. The super- 
natant, which contained mostly single cells, was transferred to fresh tubes. The cells were 
washed twice by centrifugation, counted in a hemacytometer, and diluted to give a  concen- 
tration of 5 )<  105 cells/ml. 0.1 ml samples of this suspension were transferred to small centri- 
fuge tubes and spun down. The supernatants were removed and 20 #1 volumes of the absorbed 
or unabsorbed test sera were added to each tube. The cells in the pellets were shaken into 
suspension and incubated at 37°C for 20 min. They were washed once by centrifugation and 
deposited to the bottom of the centrifuge tubes. A 30 #1 volume of a  1 in 2 dilution of guinea 
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tube.  The  cells  were  shaken  into  suspension  and  incubated  at  37°C  for  45  min.  1  drop  of 
trypan  blue  was  then  added  to  each  tube  and  approximately  100  cells were scanned  to  de- 
termine  the  percentage  which  had  taken  up  the  stain.  A  cytotoxic  index  was  calculated  for 
each tube by subtracting  the percentage of viable cells from the corresponding figure obtained 
with the control serum and dividing  the difference  by the latter figure. 
In  order  to  compare  the  absorptive  capacity  of  the  various  cells  for  the  single  pool  of 
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1:128  dilution)  by  TA3/Ha,  TA3/St,  and  TA3/Ha/ACA  clone  10  (Fig.  1  a)  and  by 
TA3/Ha/ACA  clones  2  and  6  (Fig.  1  b).  C3H  lymphocytes  served  as  target  cells for  assay 
of the cytotoxic activity of the absorbed sera. The results are expressed in terms of the cytotoxic 
index.  The activity of the unabsorbed  serum is indicated  by the dotted line. 
antiserum  that  was used  throughout,  the ratio of bound  to free antibody  (100  --  P)/P was 
calculated  by the method of Reif and plotted against the ratio  (g) of the number of cells to the 
volume  of antiserum  used in the absorption  (10).  A  regression line  through a  double log plot 
was calculated  by the method of least squares, and the value of G  (=  g when P  =  50%)  was 
interpolated.  The reciprocal,  1/G, was used as a  single numerical  estimate  for the absorptive 
capacity  of  the  different  cell  types.  Values  of  100  --  P/P  below  0.1  or above  0.9 were  not 
used  in the calculations,  because at these levels the error is too high.  The values of  1/G were 
calculated  for  1 ml of  the antiserum at the dilution used. GEORGE  KLEIN~  STEN  FRIBERG,  JR.~  AND  HENRY  HARRIS  843 
RESULTS 
Fig.  1  illustrates  individual  absorption  experiments  done  to  measure  the 
//-2~-derived K-end  antigens.  Figs.  1 a  and  1 b show  two different protocols 
where the absorptive capacity of the two TA3 lines is compared with hybrid 
clones 10  (Fig.  1 a) and 2 and 6  (Fig.  1 b), respectively. There is a more  than 
tenfold difference in the absorptive capacity of the two TA3 lines in both ex- 
periments;  TA3/St  has  much  more  antigen  than  TA3/Ha.  All  three  clones 
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FIG. 2.  Absorptive capacity of the TA3/Ha and TA3/St  lines, nine different TA3/Ha/ 
ACA hybrid  clones, and  normal A,  ACA, and  (A  X  ACA)F1 fibroblasts, tested  against 
anti-H-2  k serum. The 1/G values (see reference 10) are plotted on a logarithmic scale and 
indicate the amount of antibody bound per cell when 50% of the antibody in the serum had 
been absorbed. 
occupy an intermediate position; they do not have the absorptive capacity of 
TA3/St, but they clearly exceed TA3/Ha. Since fusion with the ACA fibroblast 
introduces H-2f antigens, which cannot cross-react in this  absorption  system, 
it must be concluded that the hybrid cells show an increased  expression of the 
K-end antigens  of the//-2  ~ complex introduced  into  the  hybrid  cell  by  the 
TA3/Ha parent, despite the fact that the hybrid cell is larger and/-/-2" receptor 
sites are intermingled with/-/-2: sites. 
A  more quantitative  way of comparing the  antigen  expression of  different 
cells is provided by the formula of Reif (10).  It was used to calculate  the ab- 844  ANTIGEN  SUPPRESSION  IN  TUMOR  CELLS 
sorptive capacity, 1/G, which expresses the amount of antibody bound  per cell 
when 50 % of the antibody is absorbed. Fig. 2 shows a logarithmic plot  of the 
1/G value for the parental and hybrid lines tested with the anti-H-2  k  serum. 
Normal parental strain and F~ fibroblasts are shown for comparison.  Each col- 
umn  is  based  on  the  results  of  at  least  three  individual  tests,  as  indicated. 
TA3/Ha absorbed significantly less than TA3/St.  Expressed in  terms of  cell 
numbers  the  difference  was  32-fold,  i.e.,  32  times  more  TA3/Ha  cells  were 
required, on average, to bind the same amount of antibody as a given number 
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FIG. 3.  Absorptive capacity of the TA3 lines, the TA3/Ha/ACA  hybrid clones, and the 
parental and hybrid fibrnblasts against anti-H-2  d serum. 
of TA3/St cells.  ACA fibroblasts absorbed no significant amount of antibody, 
as expected.  Strain A fibroblasts absorbed 7.5  times more than TA3/Ha and 
4,2  times less than TA3/St;  (A X  ACA)F1 fibroblasts absorbed 1.8 times less 
than A fibroblasts. The absorptive capacity of the homozygous TA3/St line was 
thus  approximately seven times higher  than  that of the F1 fibroblasts. These 
results  are presumably a  reflection  of  the  difference between  the  number of 
antigenic  receptors on homozygous and heterozygous cells and  also of differ- 
ences in the number of antigenic receptors on different cell  types. 
Among the TA3/Ha/ACA hybrid lines,  the  absorptive capacity of clone 2 
closely resembled that of the heterozygous fibroblast, whereas all  other clones GEORGE  KLEIN~  STEN  FRIBERG,  JR.,  AND  HENRY  HARRIS  845 
tested  had a  higher absorptive  capacity.  Clones 3B,  4,  6,  7,  10,  and  11  were 
fairly similar; their absorptive capacity was only 2.0-3.3 times less than TA3/St 
itself. Clones 5 and 12 were exceptional in that their absorptive capacity was of 
the same order as TA3/St,  or even higher. 
Fig.  3  summarizes  the  H-2 e  antigen  expression  (determined  by  the  H-2 ~ 
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FIGS.  4  a-c.  Absorption of  an anti-H-2  i  serum  (A anti-ACA serum,  dilution  1:12)  by 
TA3/St,  TA3/Ha,  ACA,  and  (A  X  ACA)Fi  fibroblasts  (Fig.  4  a)  and  by  six  different 
TA3/Ha/ACA  hybrid clones  (Figs. 4  b  and c).  Normal  ACA lymphocytes served  as target 
cells. 
complex)  of  the  different  cells.  ACA  fibroblasts  carried  no  H-2 d  antigens  as 
expected.  Strain A fibroblasts had 1.9 times more  antigen than (A X  ACA)Fi 
fibroblasts and 2.2 times less than TA3/St  cells. TA3/Ha  cells did not absorb 
enough antibody under the test conditions used to allow the calculation of l/G; 
they did, however,  carry some H-2 d  antigen since cell doses  exceeding  l0  T per 
sample showed specific removal of anti-H-2  e antibodies. 
All TA3/Ha/ACA  hybrid clones tested contained relatively high amounts of 
H-2 d  antigen, exceeding the levels found in  (A  X  ACA)Fi fibroblasts  or even 846  ANTIGEN  SUPPRESSION  IN  TUMOR  CELLS 
homozygous A fibroblasts. Clones 2, 3B, and 4 approached, but did not quite 
reach, the level as found in the TA3/St line, whereas clones 6, 7, 10, 11, and 12 
exceeded these levels.  Clone 5 was outstanding; its H-2  d antigen concentration 
was 10 times higher than that of TA3/St. 
Studies on the expression of the antigens determined by the//-2¢ complex, 
contributed to the hybrid by the normal ACA fibroblast, are illustrated by Figs. 
4 and 5. As expected, the absorption protocol shown in Fig. 4 a demonstrates 
that neither the TA3/St nor the TA3/Ha line can absorb any activity from the 
anti-ACA serum. ACA fibroblasts absorbed more antibody than (A X  ACA)F~ 
fibroblasts.  Figs.  4 b  and  4 c  illustrate  the  absorptive  capacity  of  various 
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FIG. 5.  Absorptive capacity of the TA3 lines, parental and F1 hybrid fibroblasts, and the 
TA3/Ha/ACA hybrid clones, tested against the anti-H-2  /  serum. 
TA3/Ha/ACA clones.  Clones  2,  3B, 4,  7,  and  11  had significant absorptive 
capacity, but clone 5 had no detectable H-2/ antigen. Fig. 5  shows the  1/G 
values for the H-J antigen system. Each column is based on at least three inde- 
pendent tests. Both TA3 lines lack significant absorptive capacity, as expected. 
The absorptive capacity of the homozygous ACA and the heterozygous A  X 
ACA fibroblasts differs by a factor of 4.6. This exceeds the reduction in antigen 
dosage that might be expected to occur in a heterozygote, if antigen expression 
is determined by an equal contribution from both parental genomes. It has, 
however, been found previously that sarcomas induced by methylcholanthrene 
in (A  X  ACA)F1 hybrid mice showed considerable asymmetry of antigen ex- 
pression, with an excess of H-2  ~ over H-2/antigens (11). 
All TA3/Ha/ACA hybrid clones except clone 5 contained significant amounts 
of ACA-derived H-2/antigen. The values fluctuated about the level found in GEORGE  KLEIN,  STEN  FRIBERG~  JR.,  AND  HENRY  HARRIS  8~7 
the (A X  ACA)F1 fibroblasts. Clones 3B and 7 showed somewhat higher levels 
although  they did not reach the levels found in the homozygous ACA fibro- 
blasts.  Clones 4, 6,  10,  and  12 showed levels close to the heterozygous value, 
whereas  clones  11  and  2,  particularly  the  latter,  showed  significantly lower 
values. Clone 5 appeared to contain no ACA-derived antigen. This clone had 
the  highest  absorptive  capacity  for  antibody  against  the  H-2a-determined 
H-2  k  and tt-2  d antigens  (see  Figs.  2 and 3). These two facts may be related. 
When variant sublines of H-2-heterozygous tumors are selected by passage in a 
parental strain,  the disappearance of one H-2  complex is accompanied by an 
increase in the concentration of the other, which may reach levels characteristic 
of homozygous cells (12,  13). 
DISCUSSION 
The antigenic behavior of the TA3/Ha/ACA  hybrids differs sharply from 
that previously observed in Ehrlich hybrids (1, 2). The diminished expression 
of the H-2  ~ antigens in the TA3/Ha line, which is, in all probability, responsible 
for the generalized homotransplantability of this tumor, behaves on hybridiza- 
tion as if it were a "recessive" trait. The TA3/Ha cell not only fails to suppress 
the H-21 antigens introduced into the hybrid by the ACA fibroblast, but the 
expression of its own H-2  a antigen rises to a level comparable to, or exceeding, 
that characteristic of the (A X  ACA)Fi hybrid fibroblast. This "release" from 
antigenic suppression is not dependent on the presence of the  H-2f  complex 
derived from the ACA fibroblast because in at least one hybrid clone (No. 5) 
there was no H-2  s complex, perhaps due to the loss of the corresponding chromo- 
some.  The  alternative  possibility  that  this  clone arose  from  a  TA3/Ha  X 
TA3/Ha homokaryon appears less likely since there is no obvious reason why, 
in  that  case,  the  remarkable rise in H-2  a antigen concentration should have 
occurred. 
Taken as a whole, our findings suggest that the reduced antigen expression in 
the TA3/Ha cells is due to some deficiency that can be made good by the ACA 
fibroblast. Some rate-limiting step in the synthesis of antigen may be involved 
or the mechanism by which H-2  ~ antigens are incorporated into the cell mem- 
brane. On the other hand,  the membrane structure of the TA3/Ha cell  may 
itself have changed in a way that does not allow full antigen expression. TA3/Ha 
cells differ from TA3/St in several respects. For example, unlike all other ascites 
tumors that have been investigated, including TA3/St, the TA3/Ha line cannot 
be agglutinated by concanavalin A, despite the ability of the cells to bind the 
lectin? 
The mechanism by which the Ehrlich cell suppresses surface antigens  must 
be quite different, for in hybrids between Ehrlich cells and other fully antigenic 
cells, antigenic suppression is dominant; the antigens contributed by the partner 
3 Friberg, S., Jr., S. H. Golub,  B. Lillieh56k, and A. J. Cochran. 1972. Assessment of Con- 
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cell,  whether H-2  or virus-determined, are suppressed in the hybrid.  Another 
situation where antigen suppression is recessive in the hybrid cell is the case of 
the Moloney virus (murine leukemia virus [MLV])4-determined surface antigen. 
The YACIR subline of the YAC lymphoma (14) shows greatly reduced expres- 
sion of the MLV antigen. When this celt is fused with the A9 fibroblast, full 
antigen expression is reestablished  (15).  The antigen suppression  in YACIR 
again differs from that seen in the Ehrlich cell and in hybrids derived from it. 
In the latter case, both H-Z and virus-induced surface antigens are suppressed, 
whereas in YACIR only the MLV-determined surface antigen, and not the H-2 
antigen, is suppressed. In both TA3/Ha and YACIR there is a specific defect in 
the mechanisms determining the full expression of the surface antigens and this 
defect disappears  when these cells are  fused  with  others in which  antigenic 
expression is  normal.  In  the  Ehrlich  cell  suppression  is  nonspecific affecting 
many surface antigens, and it is maintained in the hybrid cell. 
Cell  hybridization is  obviously a  useful  tool for  the  study of the  factors 
governing the expression of membrane antigens in mammalian cells and of the 
types of variation that may be encountered in the expression of these antigens. 
These variations may be of considerable importance in giving rise to "immuno- 
resistant" tumor sublines capable of escaping immunological rejection reactions. 
SUMMARY 
The Ehrlich ascites tumor, which has been subjected to prolonged selection 
for growth in aIlogeneic hosts, possesses powerful mechanisms for the suppres- 
sion  of antigens  normally found on the  cell surface.  It has previously been 
shown (1, 2) that when cells in which surface antigens are fully expressed are 
fused with Ehrlich ceils,  the suppressive mechanisms of the latter continue to 
operate and  the new  surface antigens introduced into the hybrid cell by the 
other partner are also suppressed. In the present paper we describe the proper- 
ties of hybrids in which one parent cell was the TA3 ascites carcinoma. There 
are  two  sublines  of this  carcinoma which  originally arose  as  a  spontaneous 
mammary carcinoma in a strain A mouse. The TA3/St line has a high concen- 
tration of H-2 ~ antigens and shows a  strain-specific transplantation behavior; 
the TA3/Ha subline has a drastically reduced antigen concentration and readily 
transgresses histoincompatibility barriers. The immunoresistant TA3/Ha sub- 
line arose spontaneously without having been subjected to any known immuno- 
logical selection pressure. Hybridization of TA3/Ha cells with normal diploid 
ACA fibroblasts  reestablished full  expression of  H-2 ~  antigens  in  nine  inde- 
pendently derived hybrid clones. Full reestablishment of  both D- and K-end 
components of the H-2 a complex could be demonstrated. In  some hybrid clones 
the concentration of H-2 a antigens was found to be comparable to that seen in 
(A  X  ACA)F1 fibroblasts,  whereas in others a higher  concentration was  ob- 
served, even exceeding, in some cases, the levels found in the TA3/St line.  The 
4 Abbreviation  used in this paper: MLV, murine leukemia virus. GEORGE KLEIN,  STEN FRIBERG,  JR.,  AND  HENRY HARRIS  849 
H-Y  complex, contributed by the ACA parent cell, was fully expressed in eight 
of the nine hybrid clones studied. Antigen suppression  thus behaves as a  re- 
cessive  character  in  the  TA3/Ha  hybrids,  whereas  in  the  Ehrlich  hybrids 
antigen suppression is dominant. 
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